Bioprinting technique creates thick 3D tissues composed of human stem cells and embedded vasculature, with potential applications in drug testing and regenerative medicine
A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School for Engineering and Applied Sciences (SEAS) has invented a method for 3D bioprinting thick vascularized tissue constructs composed of human stem cells, extracellular matrix, and circulatory channels lined with endothelial blood vessel cells. The resulting network of vasculature contained within these deep tissues enables fluids, nutrients and cell growth factors to be controllably perfused uniformly throughout the tissue. The advance is reported March 7 in the journal Proceedings of the National Academy of Sciences.
“This latest work extends the capabilities of our multi-material bioprinting platform to thick human tissues, bringing us one step closer to creating architectures for tissue repair and regeneration,” says Wyss Core Faculty member Jennifer A. Lewis, Sc.D., senior author on the study, who is also the Hansörg Wyss Professor of Biologically Inspired Engineering at SEAS.
To date, scaling up human tissues built of a variety of cell types has been limited by a lack of robust methods for embedding life-sustaining vascular networks. Building on their earlier work, Lewis and her team have now increased the tissue thickness threshold by nearly tenfold, setting the stage for future advances in tissue engineering and repair. The method combines vascular plumbing with living cells and an extracellular matrix, enabling the structures to function as living tissues. In the study, Lewis and her team showed that their 3D bioprinted tissues could sustain and function as living tissue architectures for upwards of six weeks.
In the study, Lewis’ team demonstrated the 3D printing of one centimeter-thick tissue containing human bone marrow stem cells surrounded by connective tissue. By pumping bone growth factors through the supporting vasculature lined with the same endothelial cells found in our blood vessels, the team induced cell development toward bone cells over the course of one month.
“This research will help to establish the fundamental scientific understanding required for bioprinting of vascularized living tissues,” Zhijian Pei, National Science Foundation Program Director for the Directorate for Engineering Division of Civil, Mechanical and Manufacturing Innovation, which funded the project. “Research such as this enables broader use of 3-D human tissues for drug safety and toxicity screening and, ultimately, for tissue repair and regeneration.”
Learn more: Scaling up tissue engineering
The Latest on: Bioprinting
[google_news title=”” keyword=”bioprinting” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Bioprinting
- CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplanton April 26, 2024 at 11:02 am
Please replace the photo for release dated April 24, 2024 with the accompanying corrected photo. This press release features multimedia. View the full release here: A) Genetically modified source pig ...
- Strategies for Successful MedTech Startups: Insights from an Experienced Innovator Strategies for Successful MedTech Startups: Insights from an Experienced Innovatoron April 26, 2024 at 10:36 am
Dr. Maria Putilina, a seasoned medical advisor and innovator, offers valuable insights into the transition from innovation consulting to startup entrepreneurship, shedding light on common pitfalls ...
- 3D Printed Silk Bio-Ink Shows Potential for Knee Meniscus Repairon April 24, 2024 at 7:00 am
Researchers have developed a silk-based bio-ink to 3D print a meniscus for better knee repair and regeneration.
- Organovo gets grant for bioprinted renal tissue for assessing renal toxicity of therapeutic agentson April 24, 2024 at 6:11 am
Assess renal toxicity with Organovo's patented bioprinted renal tubule model. Measure viability and functionality of renal cells for accurate results.
- Redwire Signs MOU with Boryung to Support its Trailblazing Humans In Space Program for Global Human Healthon April 24, 2024 at 4:30 am
Redwire Corporation (NYSE: RDW), a global leader in microgravity research, development, and manufacturing announced that it has signed a memorandum of understanding (MOU) with Boryung Corporation, a ...
- Technion breakthrough for better drug delivery and tissue implantationon April 23, 2024 at 2:11 pm
Researchers develop ultrasound for non-invasive method for bio-printing live cells and tissues deep within the body.
- 3D Cell Culture Market is expected to reach revenue of USD 5.0 Bn by 2032, at 12.0% CAGR: Insights by Dimension Market Researchon April 23, 2024 at 8:25 am
Exploring the Dynamics of the 3D Cell Culture Market by an In-Depth Analysis of Growth Trajectories, Key Players, and Future TrendsNew Jersey, New York, Los Angeles, Austin, San Diego, Philadelphia, ...
- Bainbridge, Georgia site raises ethical concerns in researchon April 23, 2024 at 2:08 am
Rather than investing in the expansion of facilities dedicated to NHPs, we should prioritize the development of scientifically robust alternatives.
- Technion scientists harness ultrasound for drug delivery and tissue implantationon April 23, 2024 at 1:48 am
Scientists from the Technion Faculty of Biomedical Engineering in Haifa made a breakthrough in drug delivery and tissue implantation, assisted by ultrasound. Prof Shulamit Levenberg’s research group ...
- Noted NASA Astronaut Stephen Bowen to Engage with Boston’s Artemis Generationon April 22, 2024 at 2:48 pm
As part of NASA’s ongoing outreach initiative Destination Station, astronaut Stephen Bowen, together with NASA and International Space Station National Laboratory representatives, will be present in ...
via Bing News